Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001062993-24-002018

Options or other derivatives

  • Chief Operating Officer acquired 87,258 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kelderman Kim Chief Operating Officer 2024-02-01 Grant or award · Restricted Stock Units +9,423 9,423 D
Kelderman Kim Chief Operating Officer 2024-02-01 Grant or award · Stock Options (Right to Buy) +25,945 25,945 D
Kelderman Kim Chief Operating Officer 2024-02-01 Grant or award · Stock Options (Right to Buy) +51,890 51,890 D
Loading xslF345X05/form4.xml…